A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 31266056.
- Also identified by DOI 10.1371/journal.pone.0218709 and PMC identifier 6606311.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
PEP Study: Ethics committee N° 393/2004, EudraCT 2004-004209-98. PEP-X Study: Ethics committee amendment application N° 154/01/2008. ClinicalTrials.gov NCT03751332.
Medical subject headings
- Cyclosporine
- Graft Rejection
- Kidney Transplantation
- Tacrolimus